Zydus MedTech, a subsidiary of Zydus Lifesciences, has entered into an exclusive agreement with Brazilian cardiovascular device manufacturer Braile Biomedica. Under this partnership, Zydus will commercialize Braile's Transcatheter Aortic Valve Implantation (TAVI) technology across Europe, India, and select global markets. The global TAVI market is valued at over USD 6 billion and is experiencing robust growth due to the increasing prevalence of aortic stenosis and the rising demand for minimally invasive cardiac procedures.